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Abstract
Deficient innate and adaptive immune responses cause newborn mammals to be more susceptible to bacterial infections
than adult individuals. Toll-like receptors (TLRs) are known to play a pivotal role in bacterial recognition and subsequent
immune responses. Several studies have indicated that activation of certain TLRs, in particular TLR-2, can result in
suppression of inflammatory pathology. In this study, we isolated peripheral blood mononuclear cells (PBMCs) from adult
and newborn horses to investigate the influence of TLR-2 activation on the inflammatory response mediated by TLR-4. Data
were analysed in a Bayesian hierarchical linear regression model, accounting for variation between horses. In general,
cytokine responses were lower in PBMCs derived from foals compared with PBMCs from adult horses. Whereas in foal
PBMCs expression of TLR-2, TLR-4, and TLR-9 was not influenced by separate and concomitant TLR-2 and TLR-4 activation, in
adult horse PBMCs, both TLR ligands caused significant up-regulation of TLR-2 and down-regulation of TLR-9. Moreover, in
adult horse PBMCs, interleukin-10 protein production and mRNA expression increased significantly following concomitant
TLR-2 and TLR-4 activation (compared with sole TLR-4 activation). In foal PBMCs, this effect was not observed. In both adult
and foal PBMCs, the lipopolysaccharide-induced pro-inflammatory response was not influenced by pre-incubation and co-
stimulation with the specific TLR-2 ligand Pam3-Cys-Ser-Lys4. This indicates that the published data on other species cannot
be translated directly to the horse, and stresses the necessity to confirm results obtained in other species in target animals.
Future research should aim to identify other methods or substances that enhance TLR functionality and bacterial defence in
foals, thereby lowering susceptibility to life-threatening infections during the first period of life.
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Introduction
Due to deficits in both innate and adaptive immune responses,
newborn mammals display increased susceptibility to bacterial
infections compared with adult individuals [1]. With regard to T
helper cell (Th) responses, newborns predominantly display Th2
responses and are deficient in eliciting Th1 responses [1,2]. In ex
vivo foal models, basal levels of Th1-related cytokines such as
interferon-c (IFN-c), tumour necrosis factor-a (TNF-a), and
interleukin-6 (IL-6) have been shown to be decreased compared
with older individuals [3–5]. In addition, monocyte-derived
dendritic cells (MoDCs) of foals have been classified as less
mature, and express limited levels of IFN-c following LPS
stimulation compared with adult cells [4]. Expression levels of
regulatory cytokines such as IL-10 and transforming growth
factor-b (TGF-b) have been documented to be limited in foals as
well [4]. In contrast, basal and stimulus-induced levels of Th2-
related cytokines such as IL-8, IL-12, and IL-23 have been shown
to be comparable in foals and older individuals [3,4]. Further-
more, in response to the specific pathogen Rhodococcus equi, no Th1-
deficits have been found in neonatal foals [3,6,7] Thus, the basal
and stimulus-induced cytokine expression in neonatal foals
appears to be selectively impaired. Similarly, in human infants,
who are biased towards Th2 responses as well, mature Th1
responses have been documented in response to Group B
Streptococci [1].
Bacterial recognition by Toll-like receptors (TLRs) and the
subsequent induction of signalling cascades have been shown to
play a pivotal role in the functional defence against pathogens, as
well as tolerance to commensal microorganisms [8,9]. The
induction of cytokine production by TLRs is crucial for both the
innate immune response itself, and the initiation of adaptive
immune responses [10]. Whereas TLR-4 responds to Gram-
negative bacteria by sensing LPS, TLR-2 mainly recognises
components of Gram-positive bacterial cell walls such as
lipoproteins, lipoteichoic acid, and lipopeptides [8]. TLR-2
interacts with bacterial lipopeptides either independently by
formation of TLR-2 homodimers, or in concert with TLR-1 or
TLR-6 by formation of heterodimers [11]. TLR-5 and TLR-9 are
activated by bacterial flagellin and specific bacterial DNA motifs,
respectively, derived from both Gram-positive and Gram-negative
bacteria [12,13].
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Dysfunction of TLRs has been associated with the occurrence of
various inflammatory disorders in mammals, amongst others an
increased susceptibility to bacterial infections and sepsis [14,15].
Several in vivo studies in experimental animals have indicated that
activation of certain TLRs, in particular TLR-2, can result in
suppression of inflammatory pathology [16–18]. In the horse,
limited research has been performed in this area, mainly focusing
on TLR-9 ligands. Ex vivo activation of TLR-9 in peripheral blood
mononuclear cells (PBMCs) isolated from neonatal foals has been
shown to enhance the Th1 response [3]. However, in another
study, antigen-presenting cells derived from foals did not respond
to TLR-9 activation with increased expression of cytokines [19].
Likewise, in vivo administration of a TLR-9 ligand in foals did not
result in a modulation of cytokine expression patterns [6]. Effects
of TLR-2 activation on basal or stimulus-induced immune
responses in the horse have not yet been described. Current
research into immunomodulation focuses either on enhancement
of TLR-dependent defensive immune responses, or suppression of
excessive TLR activity, leading to inflammation and tissue
damage. Both scenario’s could apply to immunomodulation in
horses, particularly in foals, and could contribute to lowering
susceptibility to early, often life-threatening infections.
Hence, the aim of the current study was to explore the
immunomodulatory properties of TLR-2 ligands in foals and adult
horses. For this purpose, we used PBMCs from adult horses and
newborn foals (,12 hours postpartum) to investigate the influence of
TLR-2 activation on the LPS-induced inflammatory response. We
investigated protein levels of TNF-a and IL-10, and mRNA
expression levels of TNF-a and IL-6 (Th1-related cytokines), IL-10
(regulatory cytokine), and TLR-2, TLR-4, and TLR-9 (TLRs
involved in bacterial recognition, for which the genetic sequence is
known in the horse). Data were analysed with a Bayesian
hierarchical regression model, accounting for variation between
horses.
Materials and Methods
Animals and sample collection
Six healthy adult mares and foals (NRPS and New Forest breed)
were sampled during this study. Foals were sampled within
12 hours postpartum. 60 ml of blood was collected by jugular
venipuncture directly into sterile heparinised blood collection
tubes (BD Vacutainer Systems, Plymouth, United Kingdom).
Blood samples were kept cooled during transport to the laboratory,
where PBMC isolation started within 2 hours after collection. All
experimental procedures were approved by the committee of
ethical considerations in animal experiments of Utrecht University
(DEC Utrecht, Permit Number: 2011.II.06.101).
PBMC isolation
Blood samples were diluted 1:1 in fresh PBS (Lonza, Basel,
Switzerland) containing 2 mM EDTA (Sigma- Aldrich, St. Louis)
and subsequently layered over Ficoll-PaqueTM plus (GE Health-
care, Waukesha, USA). After centrifugation (4006g, 30 minutes at
room temperature) PBMCs were pipetted from the Ficoll layer
and washed twice in PBS/EDTA. PBMCs were resuspended in
RPMI 1640 Medium (Lonza, Basel, Switzerland) containing
2 mM glutamine (Lonza, Basel, Switzerland), 100 IU/ml penicil-
lin (Lonza, Basel, Switzerland), 100 mg/ml streptomycin (Lonza,
Basel, Switzerland) and 10% horse serum (prepared in our own
laboratory by aseptically collecting blood, allowing clotting, and
centrifuging). PBMCs were counted using trypan blue and
resuspended to a density of 4*106 cells/ml medium. Following
storage overnight at 4uC to attenuate possible stimulatory effects of
the applied Ficoll, PBMCs were seeded in 24 well plates at a
density of 4*106 cells/ml medium/well.
Cell culture experiments
After seeding the PBMCs in 24 well plates, the plates were
incubated for 2 hours at 37uC and 5% CO2. Thereafter, the plates
were centrifuged for 10 minutes at 4006 g before refreshing the
medium without removing PBMCs. Before starting the experi-
ments, PBMCs were pre-incubated for 2 hours with subculturing
medium containing 0 or 1 mg/ml Pam3-Cys-Ser-Lys4 (PCSK;
Invivogen, San Diego, USA), a synthetic bacterial lipopeptide that
specifically activates TLR-2. After pre-incubation, the experiments
were started by replacing the medium with medium containing 0
or 1 mg/ml LPS (Escherichia coli O111:B4; Sigma- Aldrich, St.
Louis, USA) and 0 or 1 mg/ml PCSK. Plates were placed in the
incubator and samples for qPCR and ELISA were taken after
4 hours. Each combination of incubations was investigated in
triplicate for each horse. For the ELISAs, supernatants were stored
at 280uC. For qPCR analyses, the PBMCs were lysed using RNA
lysis buffer (Promega, Madison, USA) and stored at 280uC until
RNA isolation was resumed.
Cytokine measurements
To measure protein levels of TNF-a and IL-10, ELISA was
performed on the supernatants using DuosetH ELISA Develop-
ment System for equine TNF-a and equine IL-10 (R&D Systems,
Minneapolis, USA). Standard operating procedures of the
manufacturer were followed, applying all required buffers and
solutions in the form provided by the manufacturer (R&D
Systems, Minneapolis, USA). The detection limits of the ELISAs
were 15.6 pg/ml (TNF-a) and 156.3 pg/ml (IL-10), respectively.
RNA Isolation
RNA was isolated from PBMCs using SV Total RNA isolation
system (Promega, Madison, USA) according to the manufacturer’s
instructions. Isolated fractions were dissolved in 50 ml RNAse free
water and stored at 280uC. Quality and quantity of RNA was
determined spectrophotometrically (Nanodrop).
Real-time PCR analysis
cDNA was generated using iScriptTM cDNA Synthesis Kit
(Biorad, Hercules, USA) according to the manufacturer’s protocol.
For reverse transcriptase reaction, 1000 ng RNA was applied per
sample. Expression of mRNA was assessed by real-time PCR using
a Biorad iQ5 Multicolor Real-time PCR detection system and
iQTM SYBRH Green Supermix (Biorad, Hercules, USA). Specific
primer pairs were designed and tested for efficiency and accuracy,
after having checked their specificity using the NCBI-BLASTN
search program. Primer pairs were synthesised commercially
(Eurogentec, Maastricht, The Netherlands). For this study, mRNA
expression of TLR-2, TLR-4, TLR-9, IL-6, IL-10, TNF-a, b-
actin, and GAPDH was determined using the following primer
pairs:
TLR-2: F 59-TGCTGCCATTCTCATTCTTC-39 R 59-
GGGCCACTCCAGGTAGGT-39;
TLR-4: F 59-CCCTTTCAACTCTGCCTTCACT-39 R 59-
GGGACACCACGACAATAACTTTC-39;
TLR-9: F 59-GACTGGCTACCTGGCAAGAC-39 R 59-
GAAGCTGGCACGCAAGAG-39;
IL-6: F 59-TGGCTGAAGAACACAACAACT-39 R 59-
GAATGCCCATGAACTACAACA-39;
IL-10: F 59-GAGAACCACGGCCCAGACATCAAG-39 R 59-
GACAGCGCCGCAGCCTCACT-39;
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TNF-a: F 59-TCCAGACGGTGCTTGTGC-39 R 59-
GGCCAGAGGGTTGATTGACT-39;
b-actin: F 59-CAAGGCCAACCGCGAGAAGATGAC-39 R
59-GCCAGAGGCGTACAGGGACAGCA-39;
GAPDH: F 59-TGGCATGGCCTTCCGTGTCC-39 R 59-
GCCCTCCGATGCCTGCTTCAC-39.
Data analysis and statistical methods
Data from the second time point (4 hours incubation) were
analysed in a Bayesian hierarchical linear regression model. Log-
transformed ELISA results (log-concentrations) and qPCR results
(cycle threshold value or Ct value) were assumed to be normally
distributed. For all incubations (controls, LPS, PCSK, or
LPS+PCSK) population means of the log-concentrations and Ct
values were modelled in mares and foals, allowing responses to
differ between mares and foals. Inter-individual variation was
modelled by means of an error term at the level of horses (i.e.
assuming that PBMCs from some horses are more ‘reactive’ in
general than PBMCs from others) and incubation types within
horses (i.e. assuming that horse PBMCs may react differently to
specific incubations). Because TNF-a ELISA signals of all control
samples were below the detection limit, we assumed signal values
equal to the detection limit, leading to a conservative estimate of
differences between controls and other samples. Because IL-10
ELISA signals were mostly above the detection limit, those few
values that were below the detection limit (n = 2) were left-
censored; i.e. assuming that the ‘true’, unobserved IL-10
concentration is such that the ‘observed’ value is likely to be
under the detection limit.
Analyses were performed in JAGS, a program for analysis of
Bayesian models using Markov Chain Monte Carlo (MCMC)
simulation (version 3.2.0) [20]. Simulations in JAGS were set up
and analysed in R (version 2.14.2)[21], using packages rjags
(version 3–5) [22] and R2jags (version 0.03–06) [23]. Posterior
distributions were estimated based on uninformative prior
distributions (normal distributions with mean 0 and standard
deviation 100 for parameter means; inverse gamma distributions
with mean 1 and variance 10,000 for parameter variances).
Bayesian credible intervals (BCI) for parameter estimates were
based on the 2.5% and 97.5% percentiles of posterior distribu-
tions. Posterior distributions were simulated by means of four
Markov chains, each consisting of 30,000 Monte Carlo samples.
The first 10,000 samples were discarded for burn-in, allowing the
model to converge. Model convergence was assessed by checking
whether chains converged to the same posterior distribution, based
on Gelman and Rubin’s convergence diagnostic, the potential
scale reduction factor [24].
Differences were stated significant, based on the calculated 95%
BCI. In the results section, significant differences are quantified by
factors or percentages, though not all significant differences are
quantified in the results section. An overview of all data and the
corresponding 95% BCI’s is given in an additional file, annexed to
the manuscript (‘‘Data S1’’).
qPCR data validation
Variation of mRNA expression was excluded as a confounding
factor, as no significant differences in either b-actin or GAPDH
expression were detected amongst control samples and the
incubations with LPS, PCSK, and LPS+PCSK.
In addition, we analysed the data with a correction for these
housekeeping genes, according to the method described by Livak
and Schmittgen [25]. In our case, normalisation of data (based on
housekeeping genes) did not change point estimates for differences
between incubation types. Furthermore, normalisation did not
reduce the variation in the data (as should be expected in case of
confounding due to variation in total mRNA levels). This
indicated that the error due to variation in mRNA expression, if
any, was negligible compared to basic measurement error in the
data. Based on this knowledge and the fact that housekeeping
genes for equine PBMCs have not yet been validated, we decided
to present the data in this manuscript as they are (i.e. not
normalised).
Results
Cytokine production
ELISA results for equine TNF-a and IL-10 are illustrated in
figure 1. In comparison with controls, all tested conditions (LPS,
PCSK, and LPS+PCSK) led to a significant increase of TNF-a
and IL-10 production by PBMCs of both adult and newborn
horses (not indicated in the figure). In both age groups, TNF-a
production by PBMCs after LPS stimulation was not significantly
influenced by pre-incubation and co-stimulation of the cells with
PCSK. In contrast, IL-10 production by adult PBMCs challenged
with LPS increased significantly (1.6-fold) when the cells were co-
incubated with PCSK. In foals, this effect was not significant.
Compared with adult PBMCs, foal PBMCs produced significantly
lower amounts of TNF-a after LPS stimulation (87% lower) and
after incubation with both LPS and PCSK (83% lower).
Cytokine expression
In figure 2, the qPCR results are summarized for equine TNF-
a, IL-6, and IL-10. Basal expression levels of these cytokines did
not differ significantly between the two age groups (figure 2d). In
both age groups, expression of all measured cytokines was
relatively higher for incubations with LPS, PCSK, or both,
compared with control samples, similar to cytokine protein levels
(not indicated in the figure). Furthermore, in both age groups,
TNF-a and IL-6 expression in response to LPS was not
significantly influenced by co-stimulation with PCSK. However,
in adult PBMCs, incubation with LPS and PCSK resulted in a
significant increase in IL-10 expression (2.2-fold), whilst in
neonatal PBMCs this effect was not significant. Relative expression
of TNF-a in foal PBMCs was significantly lower compared to
adult PBMCs in all incubations (86% lower in foal PBMCs
incubated with LPS, 81% lower for PCSK, and 90% lower for
LPS+PCSK). In addition, relative expression of IL-6 was
significantly lower in foal PBMCs incubated with PCSK (63%
lower) and LPS+PCSK (73% lower). For IL-10, relative expression
was only significantly different between adult and foal PBMCs
incubated with LPS and PCSK (57% lower in foals).
TLR expression
Figure 3 summarises RT-PCR results for TLR-2, TLR-4, and
TLR-9. In control samples, TLR-2 expression was significantly
higher in foals (2.1-fold) in comparison with adults (average Ct
values were 22.98 for adult PBMCs, and 21.92 for foal PBMCs).
Basal expression of TLR-4 and TLR-9 did not differ significantly
between the two age groups (Figure 3d). Though, the difference in
basal expression of TLR-4 between the two age groups was very
close to being significant. Mean Ct values for TLR-4, calculated
from this model for adult and foal PBMCs, were 23.62 and 22.24
respectively (average DCt= 1.39, 95% BCI: 20.02–2.80), indicat-
ing a factor 2.6 difference in expression level.
In foal PBMCs, no significant change in the expression of TLR-
2, TLR-4, or TLR-9 was found in response to LPS, PCSK, or
LPS+PCSK in comparison with control samples. In contrast, in
adult PBMCs there was a significant up-regulation of TLR-2
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expression and a significant down-regulation of TLR-9 in response
to all tested TLR ligands, whereas TLR-4 expression did not
change significantly in comparison to controls. Furthermore,
TLR-2 expression was relatively lower in foal PBMCs compared
to adult PBMCs under all tested conditions (51% lower in foal
PBMCs incubated with LPS, 64% for PCSK, and 75% for
LPS+PCSK). TLR-9 expression was relatively higher in foal
PBMCs incubated with PCSK (2.3-fold) and LPS+PCSK (4.1-fold)
compared to adult PBMCs. In adult PBMCs, a significant increase
of TLR-2 and TLR-4 expression was found after incubation with
Figure 1. ELISA results for TNF-a and IL-10 in adult and neonatal PBMCs. Mean concentrations of cytokines (pg/ml) and 95% Bayesian
credible intervals are included for PBMCs incubated with blank medium (Control), with 1 mg/ml LPS, with 1 mg/ml Pam3-Cys-Ser-Lys4 (PCSK), or with a
combination of both LPS and PCSK. Compared to control samples, there was a significant increase of both TNF-a and IL-10 in response to all tested
compounds in both groups (not indicated in the figure). Significant differences between responses in adults and foals are indicated with an asterisk
(*). A significant difference between the LPS response and the response to LPS+PCSK (within the same age group) is indicated with a hash (#).
doi:10.1371/journal.pone.0066897.g001
Figure 2. qPCR results for TNF-a, IL-6, and IL-10 in adult and neonatal PBMCs. In Figure 2a, 2b, and 2c, mean values and 95% Bayesian
credible intervals are given for relative expression levels (compared to controls and LPS stimulated cells) in PBMCs incubated with blank medium
(Control), 1 mg/ml LPS, with 1 mg/ml Pam3-Cys-Ser-Lys4 (PCSK), or with a combination of both LPS and PCSK. Compared to control samples, there was
a significant increase of both TNF-a, IL-6, and IL-10 in response to all tested conditions in both age groups (not indicated in the figure). In Figure 2d,
estimated means for Ct values and 95% Bayesian credible intervals are stated for basal cytokine expression levels in both groups. Significant
differences between responses in adults and foals are indicated with an asterisk (*). A significant difference between the LPS response and the
response to LPS+PCSK (within the same age group) is indicated with a hash (#).
doi:10.1371/journal.pone.0066897.g002
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LPS+PCSK compared to LPS alone (1.6-fold increase for TLR-2,
1.8-fold for TLR-4). In contrast, in LPS challenged foal PBMCs,
pre-incubation and co-stimulation with PCSK did not lead to
changes in TLR-2 or TLR-4 expression levels. TLR-9 expression
in response to LPS was not significantly influenced by co-
stimulation with PCSK in either group.
Discussion
Cytokine production and expression
Our data show that the TNF-a response in foal PBMCs
following LPS stimulation do not reach the level of adult PBMCs.
This finding is in line with previously published results, demon-
strating that in newborn foals, the cytokine response to external
challenges like LPS, including Th-1 related and regulatory
cytokines, is lower than that of adult individuals [1–3]. However,
Me´rant et al [4] documented comparable TNF-a expression levels
after LPS challenge in foal and adult MoDCs. Most likely, this
apparent discrepancy is caused by the difference in age of the
tested foals. Me´rant et al [4] sampled 2–3 weeks old animals,
whereas the study population in the experiment described here
comprised true neonates, sampled within 12 hours postpartum. The
limited expression and production of IL-10 we documented in LPS
challenged foal PBMCs compared to adult PBMCs was consistent
with the limited IL-10 mRNA expression levels in LPS challenged
MoDCs derived from foals [4]. Apparently, in the foal, the TNF-a
response matures earlier in life compared with the IL-10 response.
In our experimental model, TNF-a production after LPS
challenge was not significantly influenced by pre-incubation and
co-stimulation with PCSK in either age group. On the other hand,
TLR-2 stimulation in addition to TLR-4 activation resulted in a
significant increase of IL-10 production in adult PBMCs (1.6-fold).
In foals, this effect was not observed. This increase of IL-10
production (and not TNF-a) as a result of concomitant TLR-2
stimulation fits the hypothesis that TLR-2 ligands exhibit anti-
inflammatory properties, as the secretion of IL-10 activates
regulatory T cells, which subsequently will produce IL-10 and
TGF-b. As a result of these cytokines, Th1, Th2, and Th17
responses are suppressed [26,27].
Regarding the differences in cytokine production between
PBMCs incubated with TLR-2 or TLR-4 ligands, our results are
in agreement with the existing literature on mammalian species
[28,29]. We found that TLR-2 activation resulted in a relatively
mild inflammatory response, whereas TLR-4 activation triggered
a marked inflammatory response, characterised by a high peak of
TNF-a production after 4 hours of incubation with LPS. This
pattern was evident in both adult and foal PBMCs.
TLR expression
TLR expression levels in foals were stable under all different
experimental conditions. In contrast, in adult PBMCs, significant
up-regulation of TLR-2 and down-regulation of TLR-9 were
evident after both separate and concomitant TLR-2 and TLR-4
activation. Expression of TLR-4 did not change significantly.
Figure 3. qPCR results for TLR-2, TLR-4, and TLR-9 in adult and neonatal PBMCs. In Figure 3a, 3b, and 3c, mean values and 95% Bayesian
credible intervals are given for relative expression levels (compared to controls and LPS stimulated cells) in PBMCs incubated with blank medium
(Control), 1 mg/ml LPS, with 1 mg/ml Pam3-Cys-Ser-Lys4 (PCSK), or with a combination of both LPS and PCSK. In adult PBMCs, significant up-
regulation of TLR-2 expression and significant down-regulation of TLR-9 was found in response to LPS, PCSK, and LPS+PCSK (not indicated in the
figure). In Figure 3d, estimated means for Ct values and 95% Bayesian credible intervals are stated for basal TLR expression levels in both groups.
Significant differences between responses in adults and foals are indicated with an asterisk (*). A significant difference between the LPS response and
the response to LPS+PCSK (within the same age group) is indicated with a hash (#).
doi:10.1371/journal.pone.0066897.g003
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Besides clear differences in the regulation of TLR expression levels
between PBMCs derived from newborn and adult horses, these
qPCR results also demonstrate TLR crosstalk in this experimental
model, as the expression of TLR-2 and TLR-9 was significantly
influenced by both TLR-2 and TLR-4 activation. Remarkable was
that though TLR expression rates in foal PBMCs were not
influenced by the used TLR ligands (in contrast to adult PBMCs),
basal TLR expression levels in foal PBMCs tended to be higher
than in adult PBMCs.
Our observation of coinciding lower cytokine responses and
higher TLR expression levels in PBMCs derived from neonatal
foals suggests that TLR signalling is impaired in newborn foals
compared with adult horses. Moreover, our data illustrate that in
foals, TLR expression levels are not influenced by a challenge with
bacterial patterns, representing either Gram-negative or Gram-
positive bacteria, in contrast to adult horses. Such a limited TLR
function is essential in neonates, as the transition from the sterile
womb into an environment full of micro-organisms would lead to
exaggerated inflammatory responses and subsequent pathology if
all TLR signalling pathways were fully operational. Tolerance to
commensal flora is a prerequisite for bacterial colonisation of
epithelial surfaces including the gut. The relatively high TLR
expression levels, which were found in foals, might facilitate more
profound defensive responses towards specific pathogens, if
necessary. For instance, Rhodococcus equi is a specific pathogen that
elicits mature defensive responses in young foals [6,7]. The
challenge for future research in this area is to find methods or
ligands that enhance TLR functionality and bacterial defence
mechanisms in young foals without interfering with the physio-
logical process of bacterial tolerance and colonisation.
Ligation of TLR-2 by different compounds
PCSK is a confirmed TLR-2 agonist, which is often applied in
the published literature throughout the past decades. Nonetheless,
other compounds have been described as TLR-2 ligands as well.
PCSK binds to TLR-2/TLR-1 heterodimers and does not interact
with TLR-6, unlike other TLR-2 agonists [30]. Long et al [31]
compared effects of four different TLR-2 agonists, including
PCSK. Though all tested TLR-2 ligands were shown to activate
NFkB and MAPK signalling pathways in murine macrophages,
the degree of activation differed among the tested compounds.
Moreover, significant differences were documented in cytokine
responses as well as the in vivo recruitment of leukocytes in a
murine model of acute inflammation. Thus, although we can
conclude that TLR-2 was ligated in our model, we cannot exclude
that other TLR-2 agonists would possibly modulate the inflam-
matory responses in this equine model differently.
Conclusion
The obtained data demonstrate a distinct regulation of cytokine
and TLR expression levels in foal and adult PBMCs in response to
TLR-2 and TLR-4 activation. While TLR expression levels were
high in foals, the lower functional response following TLR
activation in neonatal foals can be considered as a strategy to
limit the immune responses to the bacterial colonisation of
epithelial surfaces during the first period of life. In turn, the
relatively high TLR expression levels in foals might be responsible
for the previously described marked immune responses to specific
pathogens, such as Rhodococcus equi. PCSK, which has been shown
to alter inflammatory responses beneficially in previously studied
experimental models by activating TLR-2, did not exhibit
comparable properties in our model. Hence, PCSK does not
seem to be a promising candidate for immunomodulation in foals.
This indicates that translation of findings from one animal species
to another is limitedly possible and requires confirmation. It
remains a challenge for future research to identify substances or
methods, which enhance TLR functionality and bacterial defence
in young foals without causing an exaggerated inflammatory
response or interfering with bacterial colonisation.
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